OmnilinX Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

OmnilinX Therapeutics General Information

Description

Developer of novel drugs designed for the treatment of human diseases. The company is currently operating in stealth mode.

Contact Information

Website
www.omnilinxtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Grabenstrasse 3
  • 8952 Schlieren
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • Grabenstrasse 3
  • 8952 Schlieren
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OmnilinX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Nov-2026 Completed Stealth
To view OmnilinX Therapeutics’s complete valuation and funding history, request access »

OmnilinX Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
BiomedVC Venture Capital Minority
Xista Science Ventures Venture Capital Minority
To view OmnilinX Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

OmnilinX Therapeutics FAQs

  • When was OmnilinX Therapeutics founded?

    OmnilinX Therapeutics was founded in 2023.

  • Where is OmnilinX Therapeutics headquartered?

    OmnilinX Therapeutics is headquartered in Schlieren, Switzerland.

  • What industry is OmnilinX Therapeutics in?

    OmnilinX Therapeutics’s primary industry is Biotechnology.

  • Is OmnilinX Therapeutics a private or public company?

    OmnilinX Therapeutics is a Private company.

  • What is OmnilinX Therapeutics’s current revenue?

    The current revenue for OmnilinX Therapeutics is .

  • Who are OmnilinX Therapeutics’s investors?

    BiomedVC and Xista Science Ventures have invested in OmnilinX Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process